Valeant Pharmaceuticals InternationalAliso Viejo, CA, United States (NYSE: VRX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Valeant Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 08 Dec 07 Dec 06
Revenue 657.0 872.2 907.2
Cost of Goods Sold 167.9 233.1 257.0
Gross Profit 489.1 639.1 650.3
Gross Profit Margin 74.4% 73.3% 71.7%
SG&A Expense 278.0 371.0 117.2
Depreciation & Amortization 50.0 71.6 71.9
Operating Income (125.9) 94.2 13.9
Operating Margin -- 10.8% 1.5%
Nonoperating Income (9.5) 1.1 1.2
Nonoperating Expenses (13.4) -- --
Income Before Taxes (156.3) 51.3 (29.8)
Income Taxes 33.9 25.2 34.2
Net Income After Taxes (190.3) 26.1 (64.1)

Continuing Operations (190.3) 26.1 (64.1)
Discontinued Operations 166.5 (32.2) 7.5
Total Operations (23.7) (6.2) (56.6)
Total Net Income (23.7) (6.2) (56.6)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (0.27) (0.07) (0.61)
Dividends per Share 0.00 0.00 0.23
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy